Skip to main content
Eliot Brinton, MD, Endocrinology, Salt Lake City, UT, Intermountain Medical Center

EliotAshbyBrintonMDFAHA, FNLA

Endocrinology Salt Lake City, UT

Diabetes, Lipid Metabolism

President, Utah Lipid Center; President Atherometabolism Institute

Dr. Brinton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Brinton's full profile

Already have an account?

  • Office

    Utah Lipid Center
    421 S Wakara Way, Ste 121
    Salt Lake City, UT 84108
    Phone+1 801-403-7530
    Fax+1 801-606-7279
  • Is this information wrong?

Summary

  • Dr. Eliot Brinton is an endocrinologist in Salt Lake City, UT and is affiliated with Intermountain Medical Center. He received his medical degree from University of Utah School of Medicine and has been in practice 39 years. He also speaks multiple languages, including Spanish. He specializes in lipid metabolism and is experienced in obesity and obesity-related disorders, lipid metabolism disorders, diabetes mellitus type 2, ldl apheresis, and estrogen replacement.

Education & Training

  • University of Washington
    University of WashingtonFellowship, Endocrinology, Diabetes, and Metabolism, 1981 - 1984
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1978 - 1981
  • University of Utah School of Medicine
    University of Utah School of MedicineClass of 1978

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1997 - Present
  • UT State Medical License
    UT State Medical License 2003 - 2026
  • NC State Medical License
    NC State Medical License 1978 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Clinical LipidologyBoard Certified Clinical Lipidologist

Awards, Honors, & Recognition

  • Robert I. Levy Award Lipoprotein Kinetics and Metabolism Society, 2012
  • Merit Review Award Veterans Administration, 1998

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Meeting the Needs of Patients, Not LDL-C Goals: The Role of PCSK9 Inhibitor 
    ENDO 2019 - New Orleans, LA - 3/25/2019

Press Mentions

  • Prescription Omega-3 Fatty Acid Medications Effectively Lower High Triglycerides
    Prescription Omega-3 Fatty Acid Medications Effectively Lower High TriglyceridesAugust 21st, 2019
  • Amarin’s Vascepa, AstraZeneca’s Epanova Theoretical Cardiovascular Risk Reduction Class Effect Possibly Stifled
    Amarin’s Vascepa, AstraZeneca’s Epanova Theoretical Cardiovascular Risk Reduction Class Effect Possibly StifledJune 17th, 2019
  • Finding a Path Forward: The Continued Unmet Medical Need in FCS
    Finding a Path Forward: The Continued Unmet Medical Need in FCSJanuary 30th, 2019
  • Join now to see all

Grant Support

  • Estrogen Replacement Therapy In Post-Menopausal WomenNational Center For Research Resources1995–1997
  • High Density Lipoprotein (HDL) Turnover StudiesNational Center For Research Resources1994–1995
  • Regulation Of HDL Levels By Genetic And Environmental FactorsNational Center For Research Resources1987–1992
  • Molecular Genetic Control Of HDL Apoprotein MetabolismNational Heart, Lung, And Blood Institute1991
  • Molecular Genetic Control Of HDL Apoprotein MetabolismNational Heart, Lung, And Blood Institute1987–1990
  • Diet And Drug Effects On HDL MetabolismNational Center For Research Resources1985–1986

Other Languages

  • Spanish

Hospital Affiliations